Insider · CIK 0001055404
Patrick G Lepore
Files at YARW (VYNE Therapeutics Inc.). First filing Jan 16, 2025, latest Jan 16, 2025.
Patrick G Lepore files SEC Form 4 as director at YARW (VYNE Therapeutics Inc.). Since Jan 16, 2025, Patrick G Lepore has reported 1 open-market buy worth $44k and 0 open-market sells worth $0, the latest filed on Jan 16, 2025.
A track record needs three past buys with six months of prices behind them; Patrick G Lepore has 0, so none is measured yet.
The newest scored trade: bought $44k of YARW on Jan 15, 2025, filed Jan 16, 2025, scored 27 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
YARW: VYNE Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | YARWbuy VYNE Therapeutics Inc. | $44k 15,000 shares | +41% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | YARW VYNE Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 15, 2025 |
| Jan 15, 2025 | YARW VYNE Therapeutics Inc. | POpen-market purchase Common Stock | +15,000 | $2.92 | $44k | 51,472 | Jan 16, 2025 |
| Dec 12, 2024 | YARW VYNE Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +20,000 | $0.00 | $0 | 20,000 | Dec 13, 2024 |
Questions about Patrick G Lepore
Answered from the filings on this page, as of the latest one.
Is Patrick G Lepore buying or selling?
Not in the last 12 months. Patrick G Lepore's latest open-market trade on SEC Form 4 was bought $44k of YARW on Jan 15, 2025.
How did Patrick G Lepore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Patrick G Lepore has 0.
Where does Patrick G Lepore file Form 4?
Patrick G Lepore has filed Form 4 at YARW (VYNE Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.